2022 American Transplant Congress
Impact Of Nirmatrelvir-Ritonavir On Tacrolimus Concentrations
1University of Rochester Medical Center, Rochester, NY, 2Tampa General Hospital, Tampa, FL
*Purpose: Ritonavir (RTV), a component of the oral antiviral agent nirmatrelvir-RTV (Paxlovid) for COVID-19 infection, increases tacrolimus concentrations through strong competitive inhibition of gastrointestinal and…2022 American Transplant Congress
Defatting of Steatotic Liver Grafts by Normothermic Ex Vivo Liver Machine Perfusion with 2,4 Dinitrophenol
*Purpose: The purpose of the study is to demonstrate that steatotic liver grafts can be defatted by normothermic ex vivo liver machine perfusion (NEVLP) with…2022 American Transplant Congress
Trends of Living Kidney Donor Characteristics in the United States from 2000-2019
*Purpose: While studies have been performed analyzing recipient outcomes after extended criteria living donor kidney transplantation (LDKT), the actual long-term trends of demographic and medical…2022 American Transplant Congress
Simultaneous Liver and Kidney Transplantation and Gender Disparities in Transplant Access and Outcomes
*Purpose: The frequency of simultaneous liver-kidney transplantation (SLKT) has been rising since the implementation of the Model for End-stage Liver Disease (MELD)-liver allocation system in…2022 American Transplant Congress
Implementation of Robotic Approach for Living Donor Nephrectomy in a High-Volume Laparoscopic Centre
*Purpose: There are not many studies comparing robotic with laparoscopic living donor nephrectomies. Our aim was to report the outcomes of our initial experience with…2022 American Transplant Congress
Preemptive Therapy for Cytomegalovirus (CMV) Disease Prevention in High-Risk CMV Donor Seropositive Recipient Seronegative (D+/R-) Liver Transplant Recipients in a Real-World Setting
*Purpose: Preemptive therapy (PET) has demonstrated superiority to antiviral prophylaxis for prevention of cytomegalovirus (CMV) disease in CMV donor seropositive/recipient seronegative (D+R-) liver transplant recipients …2022 American Transplant Congress
Sars-cov2 Antibody Kinetics and Durability Three and Six Months After Two-Doses of MRNA Vaccination in Liver Transplant Recipients
*Purpose: nti-spike antibody response to SARS-CoV-2 vaccination is diminished in LT recipients compared to the general population so understanding durability for those that do respond…2022 American Transplant Congress
Four-Year Patient Survival After Simultaneous Pancreas-Kidney Transplantation According to Graft Status Using Kaplan-Meier Survival Method and Competing Risk Model
*Purpose: Aim of this study is to compare the patient survival submitted to SPKT according to the status of graft losses, kidney, pancreas, or both…2022 American Transplant Congress
Does Dialysis Modality or Duration Influence Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients?
*Purpose: The influence of dialysis modality and duration on outcomes following simultaneous pancreas-kidney transplantation (SPKT) remains uncertain. The study purpose was to review our single…2022 American Transplant Congress
Using Wearable Technology to Assess Activity in Children After Heart Transplant
*Purpose: Evaluating activity tolerance following heart transplant (HT) provides an objective marker of functional status, can guide cardiac rehabilitation, identifies those patients with increased cardiovascular…
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 190
- Next Page »